CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-26 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Exercise or conversion · Restricted Stock Unit Award | −2,625 | 0 | ||
| 2019-02-26 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion | +1,100 | 29,138 | ||
| 2019-02-26 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Shares withheld for taxes | −324 | $33.92 | $11K | 28,814 |
| 2019-02-26 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion · Restricted Stock Unit Award | −1,100 | 0 | ||
| 2019-02-21 | Wysenski Nancy Director | Purchase | +3,857 | $33.09 | $128K | 3,857 |
| 2019-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +121,000 | 121,000 | ||
| 2019-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Restricted Stock Unit Award | +129,600 | 129,600 | ||
| 2019-02-21 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +382,200 | 382,200 | ||
| 2019-02-21 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +90,600 | 90,600 | ||
| 2019-02-21 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +23,300 | 23,300 | ||
| 2019-02-21 | Robinson James A. Jr. President & COO,Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +40,400 | 40,400 | ||
| 2019-02-21 | Robinson James A. Jr. President & COO,Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +157,000 | 157,000 | ||
| 2019-02-21 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Grant or award · Employee Stock Option (Right to Buy) | +106,700 | 106,700 | ||
| 2019-02-21 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Grant or award · Restricted Stock Unit Award | +27,500 | 27,500 | ||
| 2019-02-21 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +106,700 | 106,700 | ||
| 2019-02-21 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +27,500 | 27,500 | ||
| 2019-02-21 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Grant or award · Employee Stock Option (Right to Buy) | +90,600 | 90,600 | ||
| 2019-02-21 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Grant or award · Restricted Stock Unit Award | +23,300 | 23,300 | ||
| 2019-02-21 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Grant or award · Employee Stock Option (Right to Buy) | +74,500 | 74,500 | ||
| 2019-02-21 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Grant or award · Restricted Stock Unit Award | +19,200 | 19,200 |
Page 84 of 90 · 1,796 trades